» Articles » PMID: 4870276

In Vitro Activity of Carbenicillin Against Gram-negative Bacilli

Overview
Journal J Bacteriol
Specialty Microbiology
Date 1968 May 1
PMID 4870276
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The activity of a new semisynthetic penicillin, carbenicillin, was determined against 241 strains of gram-negative bacilli with the tube-dilution technique. Of 143 strains of Pseudomonas sp., 99 had a minimal inhibitory concentration of 200 to 300 mug/ml. The majority of strains of Escherichia coli and Proteus spp. were sensitive to this antibiotic, with minimal inhibitory concentrations of 25 mug/ml or less. Strains of Klebsiella sp. were quite resistant to carbenicillin. The size of inoculum had no significant effect on the minimal inhibitory concentration for Pseudomonas sp.

Citing Articles

Human pharmacology of 6-[D-alpha-(3-guanylureido)-phenylacetamido]-penicillanic acid (BL-P1654).

Bodey G, Horikoshi N, Rodriguez V Antimicrob Agents Chemother. 1974; 5(4):366-70.

PMID: 15825389 PMC: 428976. DOI: 10.1128/AAC.5.4.366.


Comparative in vitro evaluation of BL-P1654 and carbenicillin against Pseudomonas.

Overturf G, Ressler R, Wilkins J Antimicrob Agents Chemother. 1974; 6(5):643-6.

PMID: 15825320 PMC: 444707. DOI: 10.1128/AAC.6.5.643.


Susceptibility of Pseudomonas aeruginosa to carbenicillin.

Traub W, RAYMOND E Appl Microbiol. 1970; 20(4):630-2.

PMID: 5498614 PMC: 377005. DOI: 10.1128/am.20.4.630-632.1970.


Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.

Meyer R, Young L, Armstrong D Appl Microbiol. 1971; 22(6):1147-51.

PMID: 5002900 PMC: 376501. DOI: 10.1128/am.22.6.1147-1151.1971.


In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin.

Phair J, Watanakunakorn C, Bannister T Appl Microbiol. 1969; 18(3):303-6.

PMID: 4984762 PMC: 377973. DOI: 10.1128/am.18.3.303-306.1969.


References
1.
Stone H, Kolb L . Gentamicin sulfate in the treatment of extra-urinary infections due to gram-negative bacteria. South Med J. 1967; 60(2):142-4. DOI: 10.1097/00007611-196702000-00009. View

2.
Brumfitt W, Percival A, Leigh D . Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. Lancet. 1967; 1(7503):1289-93. DOI: 10.1016/s0140-6736(67)91590-5. View

3.
Acred P, Brown D, KNUDSEN E, Rolinson G, Sutherland R . New semi-synthetic penicillin active against Pseudomonas pyocyanea. Nature. 1967; 215(5096):25-30. DOI: 10.1038/215025a0. View

4.
Hersh E, Bodey G, NIES B, Freireich E . CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963. JAMA. 1965; 193:105-9. DOI: 10.1001/jama.1965.03090020019005. View